Effects of p-hydroxyacetophenone on bile secretion and blood lipid levels in rats
-
摘要: 目的 研究对羟基苯乙酮（PHA）促胆汁分泌和降血脂作用以及初步作用机制。 方法 正常SD大鼠行胆管插管术，收集给药前30 min和给药后3 h分泌的胆汁，测定胆汁单位时间内的分泌量和胆汁成分；建立大鼠高血脂模型，观察PHA的降胆固醇作用；制备正常大鼠可溶性HMG-CoA还原酶，测定PHA对HMG-CoA还原酶活性的影响；对大鼠高胆固醇血症实验中得到的动物肝脏样本，进行Real-time PCR试验。 结果 PHA可以增加实验大鼠胆汁和胆汁酸的分泌量；同时能够显著降低高胆固醇血症大鼠的胆固醇水平，具有调血脂作用；初步的作用机制研究显示，PHA抑制HMG-CoA还原酶活性的作用较弱，但可以促进影响胆汁酸外排及胆固醇转化的AQP8、CYP7A1、OATP、NTCP等基因的转录。 结论 PHA作为茵陈中一种有效的单体化合物，可用于促进胆汁分泌、调节血脂代谢药物的研发。Abstract: Objective To study the effects and mechanism of p-hydroxyacetophenone (PHA) on bile secretion, cholesterol metabolism and blood lipids. Methods Cystic duct cannula was cannulated and bile were collected in SD rats.PHA was administrated in the high cholesterol rats. The activity of HMG-CoA reductase was determined by spectrophotometry in reaction system. Samples of liver were obtained in experiment hypercholesterolemia rats and Real-time PCR test was conducted for AQP8, CYP7A1, OATP and NTCP. Results Secretion of bile were increased, cholesterol in bile were reduced and secretion of total bile acid were increased in rats by PHA. The level of serum cholesterol in hyperglycemia rat model was reduced significantly and inhibitory ability had been limited in the activity of HMG-CoA reeducates by PHA, but the gene transcription including AQP8, CYP7A1, OATP, and NTCP were promoted, which are related to function of excretion of biliary acid and transformation of cholesterol. Conclusion These results suggest that PHA, as a lead compound, might be of significance for further development for a bile secretory and lipid lowering agent.
-
Key words:
- p-hydroxyacetophenone(PHA) /
- artemisiae capillaries /
- choleretic /
- cholesterol
-
[1] 胡熙明,张文康,朱庆生,等.中华本草(第7册)[M].上海:上海科学技术出版社,1999:687-693. [2] 谢韬, 梁敬钰, 刘净. 茵陈化学成分和药理作用研究进展[J]. 海峡药学, 2004, 16(1):8-13. [3] 曹锦花.茵陈的化学成分和药理作用研究进展[J].沈阳药科大学学报,2013,30(6):489-494. [4] 董岩,王新芳,崔长军,等. 茵陈蒿的化学成分和药理作用研究进展[J]. 时珍国医国药, 2008, 19(04):874-876. [5] Yoon M,Kim MY.The anti-angiogenic herbal composition Ob-X from Morus alba,Melissa officinalis, and Artemisia capillaris regulates obesity in genetically obese ob/ob mice[J]. Pham Biol,2011,49(6):614-619. [6] 向怀,覃薛文.茵陈清热利胆汤治疗妊娠期肝内胆汁淤积症30例总结[J].湖南中医杂志,2013,29(6):49-50. [7] 张林丽. 茵陈的药理研究和临床应用近况[J]. 广西医学,2003, 25(11):2184-2185. [8] 李佳佳,罗贞恋,覃川,等.茵陈蒿汤加味方对高脂血症小鼠血清总胆固醇和甘油三酯影响的实验研究[J].贵阳中医学院学报, 2014, 36(6):24-27. [9] Richard A J, Fuller S, Fedocenco V, et al. Artemisia scoparia enhances adipocyte development and endocrine function in vitro and enhances insulin action in vivo[J]. PLoS ONE,2014, 9(6):e98897. [10] 王喜军,李廷利,孙晖.茵陈蒿汤及其血中移行成分6,7二甲氧基香豆素的肝保护作用[J].中国药理学通报,2004,20(2):239-240. [11] 阙金花,黄鸣清,郑海音,等. 复方熊胆茵陈颗粒的保肝、降血脂、抗脂肪肝药效学研究[J]. 中国医院药学杂志, 2015,35(19):1736-1740. [12] Wang Z Q, Zhang X, Yu Y, et al. Artemisia scoparia extract attenuates non-alcoholic fatty liver disease in diet-induced obesity mice by enhancing hepatic insulin and AMPK signaling independently of FGF21 pathway[J].Metab Clin Exp, 2013, 62(9):1239-1249. -
点击查看大图
计量
- 文章访问数: 3228
- HTML全文浏览量: 381
- PDF下载量: 701
- 被引次数: 0
下载:
